Abnormalities in renal tubular phosphate handling in children with sickle cell disease

Pediatric Blood and Cancer

Volumn 61, Issue 12, 2014, Pages 2267-2270

  Raj, Vimal Master Sankar ^a   Freundlich, Michael ^a   Hamideh, Dima ^a   Alvarez, Ofelia ^a   Seeherunvong, Wacharee ^a   Abitbol, Carolyn ^a   Katsoufis, Chryso ^a   Chandar, Jayanthi ^a   Ruiz, Phillip ^b   Zilleruelo, Gaston ^a  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Estimated glomerular filtration rate; Fibroblast growth factor 23; Intact parathyroid hormone; Sickle cell disease; Tubular maximum re absorption of phosphorus per unit of GFR; Tubular re absorption of phosphorus

Indexed keywords

CALCIUM; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 23; PARATHYROID HORMONE; PHOSPHATE;

ADOLESCENT; BLOOD; COHORT ANALYSIS; COMPLICATION; CROSS-SECTIONAL STUDY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPERPHOSPHATEMIA; KIDNEY TUBULE; MALE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PROGNOSIS; SICKLE CELL ANEMIA;

ADOLESCENT; ANEMIA, SICKLE CELL; CALCIUM; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FIBROBLAST GROWTH FACTORS; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; HYPERPHOSPHATEMIA; KIDNEY TUBULES; MALE; PARATHYROID HORMONE; PHOSPHATES; PROGNOSIS;

EID: 84911463826     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.25188     Document Type: Article

References (32)

1. Pham PT, Pham PC, Wilkinson AH, et al. Renal abnormalities in sickle cell disease. Kidney Int 2000; 57:1-8.
2. Badr M, El Koumi MA, Ali YF, et al. Renal tubular dysfunction in children with sickle cell haemoglobinopathy. Nephrology 2013; 18:299-303.
3. Smith EC, Valika KS, Woo JE, et al. Serum phosphate abnormalities in sickle cell anemia. Proc Soc Exp Biol Med 1981; 168:254-258.
4. Oladipo OO, Temiye EO, Ezeaka VC, et al. Serum magnesium, phosphate and calcium in Nigerian children with sickle cell disease. West Afr J Med 2005; 24:120-123.
5. Al-Harbi N, Annobil SH, Abbag F, et al. Renal reabsorption of phosphate in children with sickle cell anemia. Am J Nephrol 1999; 19:552-554.
6. Foley RN, Collins AJ, Herzog CA, et al. Serum phosphorus levels associate with coronary atherosclerosis in young adults. J Am Soc Nephrol 2009; 20:397-404.
7. Palomino HL, Rifkin DE, Anderson C, et al. 24-hour urine phosphorus excretion and mortality and cardiovascular events. Clin J Am Soc Nephrol 2013; 8:1202-1210.
8. Park KS, Chang JW, Kim TY, et al. Lower concentrations of serum phosphorus within the normal range could be associated with less calcification of the coronary artery in Koreans with normal renal function. Am J Clin Nutr 2011; 94:1465-1470.
9. Ketteler M, Wolf M, Hahn K, et al. Phosphate a novel cardiovascular risk factor. Eur Heart J 2013; 34:1099-1101.
10. Liu S, Guo R, Simpson LG, et al. Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX. J Biol Chem 2003; 278:37419-37426.
11. Liu S, Zhou J, Tang W, et al. Pathogenic role of Fgf23 in Hyp mice. Am J Physiol Endocrinol Metab 2006; 291:E38-E49.
12. Gattineni J, Bates C, Twombley K, et al. FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1. Am J Physiol Renal Physiol 2009; 297:F282-F291.
13. Gutierrez OM, Mannstadt M, Isakova T, et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 2008; 359:584-592.
14. Bischoff-Ferrari HA. Optimal serum 25-hydroxyvitamin D levels for multiple health outcomes. Adv Exp Med Biol 2008; 624:55-71.
15. Seeherunvong W, Abitbol CL, Chandar J, et al. Vitamin D insufficiency and deficiency in children with early chronic kidney disease. J Pediatr 2009; 154:906-911.
16. Arnaud SB, Goldsmith RS, Stickler GB, et al. Serum parathyroid hormone and blood minerals: interrelationships in normal children. Pediatr Res 1973; 7:485-493.
17. Greenberg BG, Winters RW, Graham JB. The normal range of serum inorganic phosphorus and its utility as a discriminant in the diagnosis of congenital hypophosphatemia. J Clin Endocrinol Metab 1960; 20:364-379.
18. Schwartz GJ, Muñoz A, Schneider MF, et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol 2009; 20:629-637.
19. Zappitelli M, Parvex P, Joseph L, et al. Derivation and validation of cystatin C-based prediction equations for GFR in children. Am J Kidney Dis 2006; 48:221-230.
20. Lane NE, Parimi N, Corr M, et al. Association of serum fibroblast growth factor 23 (FGF23) and incident fractures in older men: The osteoporotic fractures in men (MrOS) study. J Bone Miner Res 2013; 28:2325-2332.
21. Alon U, Hellerstein S. Assessment and interpretation of the tubular threshold for phosphate in infants and children. Pediatr Nephrol 1994; 8:250-251.
22. Isakova T, Wahl P, Vargas GS, et al. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int 2011; 79:1370-1378.
23. De Jong PE, de Jong-van Denberg LT, Statius van Eps LW, et al. The tubular reabsorption of phosphate in sickle-cell nephropathy. Clin Sci Mol Med 1978; 55:429-434.
24. Christov M, Waikar SS, Pereira RC, et al. Plasma FGF23 levels increase rapidly after acute kidney injury. Kidney Int 2013; 84:776-785.
25. Burnett-Bowie SA, Leder BZ, Henao MP, et al. Randomized trial assessing the effects of ergocalciferol administration on circulating FGF23. Clin J Am Soc Nephrol 2012; 7:624-631.
26. Rovner AJ, Stallings VA, Kawchak DA, et al. High risk of vitamin D deficiency in children with sickle cell disease. J Am Diet Assoc 2008; 108:1512-1516.
27. Faul C, Amaral AP, Oskouei B, et al. FGF23 induces left ventricular hypertrophy. J Clin Invest 2011; 121:4393-4408.
28. Isakova T, Xie H, Yang W, et al. Chronic Renal Insufficiency Cohort (CRIC) StudyGroup. Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA 2011; 305:2432-2439.
29. Kendrick J, Cheung AK, Kaufman JS, et al. FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis. J Am Soc Nephrol 2011; 22:1913-1922.
30. Seiler S, Reichart B, Roth D, et al. FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment. Nephrol Dial Transplant 2010; 25:3983-3989.
31. Seeherunvong W, Abitbol CL, Chandar J, et al. Fibroblast growth factor 23 and left ventricular hypertrophy in children on dialysis. Pediatr Nephrol 2012; 27:2129-2136.
32. Dominguez JR, Shlipak MG, Whooley MA, et al. Fractional excretion of phosphorus modifies the association between fibroblast growth factor-23 and outcomes. J Am Soc Nephrol 2013; 24:647-654.